Bringing epigenetic technology and artificial intelligence to life.
Location: United States, Minnesota, Minneapolis
Total raised: $1.5M
Investors 1
| Date | Name | Website |
| - | Centrecour... | centrecour... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.06.2025 | - | $1.5M | - |
Mentions in press and media 7
| Date | Title | Description |
| 06.06.2025 | FOXO raises $1.5 million | FOXO Technologies FOXO Technologies Founded: 2016 Headquarters: Minneapolis, Minnesota, United States Total Funding: $67.87M See full company profile "> has entered into a securities purchase agreement with existing institutional in... |
| 18.06.2024 | FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital | MINNEAPOLIS, MN, June 18, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced that it has secured up to $2.8 million in Senior Notes from an institutional investor (“Investor”) to... |
| 30.10.2023 | FOXO Technologies Combines Epigenetic Data With AI for New Direct-To-Consumer Offering | Announces Collaboration and Secures Exclusive License with KR8.ai to Power New Epigenetic Wellness Solutions Related Posts DataRobot Announces New Enterprise-Grade Functionality to Close the Generative AI Confidence Gap and Accelerate Adopt... |
| 15.10.2023 | Foxo Technologies Notifies USPTO of Issue of a Patent to Enable the Commercialization of Epigenetic Biomarkers | Builds on Notices of Allowance Previously Issued by the USPTO for Two Related Patents Leveraging the Same Approaches FOXO Technologies a leader in the field of commercializing epigenetic biomarker technology announced that the United States... |
| 18.08.2023 | FOXO Technologies Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity | FOXO Technologies, a leader in the field of commercializing epigenetic biomarker technology, has advanced in its mission to utilize the power of epigenetics and artificial intelligence to generate data-driven insights that promote optimal h... |
| 24.07.2023 | FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis | FOXO Technologies , a leader in the field of commercializing epigenetic biomarker technology, announced the launch of its cutting-edge Bioinformatics Services to accelerate breakthroughs in biology, biotechnology, and healthcare, and redefi... |
| 09.02.2021 | FOXO Technologies files Form D with the SEC | Minneapolis-based FOXO Technologies FOXO Technologies Founded: 2016 Headquarters: Minneapolis, MN, US See full company profile "> filed its Form D with the SEC in connection to a debt/option round totaling $7 million. Established in... |